Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

Completed · Phase 4

Conditions studied: HIV Infections

In brief

The purpose of this clinical research study is to assess the effect of Famotidine given twice daily on Atazanavir administered with Ritonavir in HIV-Infected subjects.

Key facts

Study ID

NCT00384904

Run by

Bristol-Myers Squibb

People needed

40

Starts

2006-12-01

Expected to finish

2007-12-01

Last updated by the study team

2010-02-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-infected male and female subjects between the ages of 18 to 65 years old with a BMI 18 to 35 kg/m²
• Prior to enrollment subjects must be currently receiving Atazanavir/Ritonavir plus at least 2 NRTIs, must have plasma HIV RNA <400 copies/mL and have CD4 count >200 cells/mm³

Where it is running

• Garden State Infectious Disease Associates, Pa — Voorhees Township, New Jersey, United States
• Unc Center For Aids Research — Chapel Hill, North Carolina, United States
• Local Institution — Philadelphia, Pennsylvania, United States
• Local Institution — London, Greater London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.